Federal Cervical Cancer Collaborative to Advance Equity in Cervical Cancer Control
Overview
The Federal Cervical Cancer Collaborative (FCCC) is an offshoot of the Cancer Moonshot℠ effort to Accelerate Cervical Cancer Control, and supports the National Cancer Plan to reduce the persistent disparities in cervical cancer through more equitable cervical cancer vaccination, screening, and management among geographically isolated and economically and medically vulnerable populations in the United States.
This multi-agency partnership, with representatives from across the Department of Health and Human Services (HHS), seeks to expedite the adoption and integration of innovative approaches for cervical cancer prevention, screening, and treatment.
Background
The FCCC began as a means to speed the adoption of the 2019 ASCCP Consensus Clinical Management Guidelines in safety-net settings of care. It has since taken on many other goals.
Federal partner agencies include the Health Resources and Services Administration (HRSA) Office of Women’s Health (OWH), the National Institutes of Health (NIH) National Cancer Institute, NIH Office for Research on Women’s Health, HHS Office of Population Affairs in the Office of the Assistant Secretary for Health, HRSA Office of Intergovernmental and External Affairs, the Centers for Disease Control and Prevention (CDC) Division of Cancer Prevention and Control, and the Centers for Medicare and Medicaid Services.
NCI partners include experts from DCEG and the Division of Cancer Control and Population Sciences (DCCPS).
Goals of the FCCC
Operating within HRSA-supported and other safety-net care environments, the FCCC aims to bridge the gaps in cervical cancer care by disseminating vital information, fostering awareness, and accelerating the implementation of effective strategies.
The ultimate goal is to reduce incidence and mortality from cervical cancer.
Accomplishments to Date
Landscape Analysis Report
Partners in DCCPS led the development of a comprehensive landscape analysis describing the facilitators and barriers to effective cervical cancer screening in low-resource settings and for at-risk populations.
Roundtable Series
From 2022 to 2023, the FCCC held a series of roundtable meetings including primary care providers, oncologists, patient navigators and advocates, researchers, and members of government.
These experts shared details about the current state of cervical cancer care. They discussed challenges, areas of potential growth, and innovations. The group identified best practices for providers. They outlined ways to work in unison on a federal level.
The roundtable discussions contributed to the development of the Federal Opportunities Report and two Toolkits, one for providers and one for patients.
Federal Opportunities Report
The Federal Opportunities Report (PDF - 1 MB) documents ways to improve cervical cancer care across the federal government, at patient, provider, and system levels.
Provider Toolkit
The FCCC collaborated on the creation of a provider toolkit, to empower clinicians in safety-net settings of care, and federal opportunities report reflecting input from experts and advocates from across the country and from U.S. Virgin Islands, Puerto Rico, and the Affiliated Pacific Islands. engaged through a series of roundtables held virtually over several months in 2022.
A patient toolkit is on track to be published in 2024.
For more information, contact Nicolas Wentzensen or Jennifer Loukissas.